首页> 外文期刊>European Journal of Pharmacology: An International Journal >Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.
【24h】

Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907.

机译:多巴胺D3受体激动剂(+)-PD 128,907的非典型抗精神病药样作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Anti-schizophrenia agents with improved efficacy and side-effect profiles are required. A dopamine D3 receptor agonist, R-(+)-trans-3,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3- b]-1,4-oxazin-9-ol HCl ((+)-PD 128,907), displayed an atypical antipsychotic profile comparable to that of clozapine. (+)-PD 128,907 blocked stereotypy produced by dizocilpine (MK-801) at 12-fold lower doses than those affecting apomorphine-induced stereotypes in mice and did not produce catalepsy. These effects of (+)-PD 128,907 were stereospecific and were blocked by a D3 antagonist. These data suggest a role for D3 receptors in antipsychotic drug action.
机译:需要具有改善的功效和副作用特征的抗精神分裂症药物。多巴胺D3受体激动剂R-(+)-trans-3,4a,10b-四氢-4-丙基-2H,5H- [1]苯并吡喃并[4,3-b] -1,4-恶嗪-9- HCl((+)-PD 128,907)中显示出与氯氮平相当的非典型抗精神病药物。 (+)-PD 128,907阻止了地佐西平(MK-801)产生的定型观念,其剂量比影响阿扑吗啡诱导的小鼠定型的剂量低12倍,并且没有产生僵直症。 (+)-PD 128,907的这些作用具有立体特异性,并被D3拮抗剂阻断。这些数据表明D3受体在抗精神病药物作用中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号